TrialInternational journal of hematology2022

A phase II study of post-transplant cyclophosphamide combined with tacrolimus for GVHD prophylaxis after HLA-matched related/unrelated allogeneic hematopoietic stem cell transplantation.

Hirohisa Nakamae et al.PubMed ↗Publisher ↗

No numbers read from the abstract.